Trichosporon asahii and Candida guilliermondii as a Source of Orbital Infection in an Immunocompromised Individual

A 47-year-old male with a history of immunosuppression and recent intensive care unit admission presented with progressive orbital swelling and pain. Blood cultures grew <i>Trichosporon asahii</i> and <i>Candida guilliermondii</i>, with matching positive cultures from peripheral and central venous samples. Given his fungemia and worsening orbital involvement, induction therapy with amphotericin B and isavuconazole was initiated. Within weeks, clinical improvement was noted, prompting a transition to long-term consolidation therapy with oral posaconazole and isavuconazole. At follow-up, the patient demonstrated sustained clinical stability with no recurrence of infection. Orbital involvement from fungemia due to <i>T. asahii</i> and <i>C. guilliermondii</i> is rare, and management requires early recognition, aggressive antifungal therapy, and careful monitoring.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-02-15
DOI
https://doi.org/10.7759/cureus.79062
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trichosporon asahii and Candida guilliermondii as a Source of Orbital Infection in an Immunocompromised Individual

John Foxworth, M. Schill, Katie Hardy, David Morcos et al.
Cureus
Antifungal resistance and susceptibility
article

Trichosporon asahii and Candida guilliermondii as a Source of Orbital Infection in an Immunocompromised Individual

John Foxworth, M. Schill, Katie Hardy, David Morcos, Anthony Makovec
article en

Abstract

A 47-year-old male with a history of immunosuppression and recent intensive care unit admission presented with progressive orbital swelling and pain. Blood cultures grew <i>Trichosporon asahii</i> and <i>Candida guilliermondii</i>, with matching positive cultures from peripheral and central venous samples. Given his fungemia and worsening orbital involvement, induction therapy with amphotericin B and isavuconazole was initiated. Within weeks, clinical improvement was noted, prompting a transition to long-term consolidation therapy with oral posaconazole and isavuconazole. At follow-up, the patient demonstrated sustained clinical stability with no recurrence of infection. Orbital involvement from fungemia due to <i>T. asahii</i> and <i>C. guilliermondii</i> is rare, and management requires early recognition, aggressive antifungal therapy, and careful monitoring.

CureusVol. 17(2)
Truman Medical Center (US), Louisiana State University Health Sciences Center New Orleans (US), University of Missouri–Kansas City (US)
Openalex Percentile: Top 95%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.